These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1411847)

  • 1. Treatment of chancroid with a single dose of spectinomycin.
    Guzmán M; Guzmán J; Bernal M
    Sex Transm Dis; 1992; 19(5):291-4. PubMed ID: 1411847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chancroid with spectinomycin or co-trimoxazole.
    Traisupa A; Ariyarit C; Metheeprapha C; Buatiang A; Sungthong P
    Clin Ther; 1990; 12(3):200-5. PubMed ID: 2165860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of spectinomycin and erythromycin in the treatment of chancroid.
    Ballard RC; da L'Exposto F; Dangor Y; Fehler HG; Miller SD; Koornhof HJ
    J Antimicrob Chemother; 1990 Sep; 26(3):429-34. PubMed ID: 2146242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of single-dose spectinomycin with five days of trimethoprim-sulfamethoxazole for the treatment of chancroid.
    Fransen L; Nsanze H; Jo-Ndinya-Achola ; D'Costa L; Ronald AR; Piot P
    Sex Transm Dis; 1987; 14(2):98-101. PubMed ID: 2956702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefotaxime treatment of Haemophilus ducreyi infection in Kenya.
    Plummer FA; Maggwa N; D'Costa LJ; Nsanze H; Karasira P; Maclean IW; Ronald AR
    Sex Transm Dis; 1984; 11(4):304-7. PubMed ID: 6098034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand.
    Taylor DN; Pitarangsi C; Echeverria P; Panikabutra K; Suvongse C
    J Infect Dis; 1985 Nov; 152(5):1002-6. PubMed ID: 3876396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of 500- and 1,000-mg doses of ciprofloxacin for the treatment of chancroid.
    Bodhidatta L; Taylor DN; Chitwarakorn A; Kuvanont K; Echeverria P
    Antimicrob Agents Chemother; 1988 May; 32(5):723-5. PubMed ID: 3293526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid.
    Knapp JS; Back AF; Babst AF; Taylor D; Rice RJ
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1552-5. PubMed ID: 8363390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of treatment for chancroid in Rwanda is not related to human immunodeficiency virus infection: in vitro resistance of Haemophilus ducreyi to trimethoprim-sulfamethoxazole.
    Bogaerts J; Kestens L; Martinez Tello W; Akingeneye J; Mukantabana V; Verhaegen J; Van Dyck E; Piot P
    Clin Infect Dis; 1995 Apr; 20(4):924-30. PubMed ID: 7795096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of fleroxacin (RO 23-6240) as single-oral-dose therapy of culture-proven chancroid in Nairobi, Kenya.
    MacDonald KS; Cameron DW; D'Costa L; Ndinya-Achola JO; Plummer FA; Ronald AR
    Antimicrob Agents Chemother; 1989 May; 33(5):612-4. PubMed ID: 2502065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States.
    Motley M; Sarafian SK; Knapp JS; Zaidi AA; Schmid G
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1639-43. PubMed ID: 1416845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose therapy of chancroid with trimethoprim-sulfametrole.
    Plummer FA; Nsanze H; D'Costa LJ; Karasira P; Maclean IW; Ellison RH; Ronald AR
    N Engl J Med; 1983 Jul; 309(2):67-71. PubMed ID: 6343878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of chancroid and Haemophilus ducreyi in Nairobi, Kenya.
    Plummer FA; D'Costa LJ; Nsanze H; Dylewski J; Karasira P; Ronald AR
    Lancet; 1983 Dec; 2(8362):1293-5. PubMed ID: 6139629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-course and single-dose antimicrobial therapy for chancroid in Kenya: studies with rifampin alone and in combination with trimethoprim.
    Plummer FA; Nsanze H; D'Costa LJ; Ndugga Maggwa AB; Girouard Y; Karasira P; Albritton WL; Ronald AR
    Rev Infect Dis; 1983; 5 Suppl 3():S565-72. PubMed ID: 6635447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethoprim sulphamoxole in the treatment of chancroid. Comparison of two single dose treatment regimens with a five day regimen.
    Dylewski J; Nsanze H; D'Costa L; Slaney L; Ronald A
    J Antimicrob Chemother; 1985 Jul; 16(1):103-9. PubMed ID: 3876325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial therapy of chancroid: effectiveness of erythromycin.
    Plummer FA; D'Costa LJ; Nsanze H; Maclean IW; Karasira P; Piot P; Fast MV; Ronald AR
    J Infect Dis; 1983 Oct; 148(4):726-31. PubMed ID: 6355314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiamphenicol in the treatment of chancroid in men.
    Latif AS; Crocchiolo PR; Lencioni R
    Sex Transm Dis; 1984; 11(4 Suppl):454-5. PubMed ID: 6335300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance of Haemophilus ducreyi.
    Rutanarugsa A; Vorachit M; Polnikorn N; Jayanetra P
    Southeast Asian J Trop Med Public Health; 1990 Jun; 21(2):185-93. PubMed ID: 2237585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of Haemophilus ducreyi to spectinomycin in vitro.
    Hafiz S; Jones BM; Kinghorn GR; Duerden BI
    Genitourin Med; 1986 Aug; 62(4):251-2. PubMed ID: 2942458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chancroid in Sheffield. A report of 22 cases diagnosed by isolating Haemophilus ducreyi in a modified medium.
    Hafiz S; Kinghorn GR; McEntegart MG
    Br J Vener Dis; 1981 Dec; 57(6):382-6. PubMed ID: 6976815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.